Buru Babirusa vs

Babyrousa babyrussa compared with Clitopilus passeckerianus

Key Differences

• Buru Babirusa is Vulnerable while is Not Evaluated.

Taxonomic Classification

Rank	Buru Babirusa
Kingdom	Animalia (Animals)	Fungi (Fungi)
Phylum	Chordata (Chordates)	Basidiomycota (Club Fungi)
Class	Mammalia (Mammals)	Agaricomycetes (Mushrooms)
Order	Artiodactyla (Even-toed Ungulates)	Agaricales (Gilled Mushrooms)
Family	Suidae (Pigs)	Entolomataceae
Genus	Babyrousa	Clitopilus
Species	Babyrousa babyrussa	Clitopilus passeckerianus

Conservation Status

Buru Babirusa

VU — Vulnerable

NE — Not Evaluated

Physical Characteristics

Attribute	Buru Babirusa
Diet	—	—
Average Lifespan	—	—
Average Length	—	—
Average Weight	—	—

Habitat & Geographic Range

Buru Babirusa

Habitat

Typically found in diverse terrestrial and aquatic ecosystems.

Habitat

Typically found in forest floors, decomposing wood, and soil ecosystems.

Range

Distributed across Norway and Sweden.

Buru Babirusa

The Buru Babirusa (Babyrousa babyrussa) is a species in the genus Babyrousa. It is currently classified as Vulnerable on the IUCN Red List. Typically found in diverse terrestrial and aquatic ecosystems.

Clitopilus passeckerianus is a white-rot agaric fungus in the family Entolomataceae notable for its role as a natural producer of pleuromutilin, a diterpenoid antibiotic compound that serves as the biosynthetic precursor for the veterinary and human antibiotic drugs tiamulin and valnemulin, used to treat Mycoplasma infections in livestock. First described from European woodland habitats, the species produces the characteristic Clitopilus fruiting body: a pale, whitish cap with decurrent, crowded gills becoming pinkish at maturity from angular spores, and a farinaceous odor. Its antibiotic-producing capacity makes C. passeckerianus of significant pharmaceutical interest, and biosynthetic studies of pleuromutilin production have informed synthetic chemistry approaches to antibiotic development. The species inhabits temperate deciduous woodland floors in Europe, fruiting in autumn among leaf litter. Discovery of its pleuromutilin biosynthetic pathway has opened avenues for heterologous expression and semi-synthetic modification aimed at developing novel antibiotics to counter antibiotic-resistant bacterial pathogens.